# GIVLAARI
> **NDA212194** · New Drug Application · Sponsor: ALNYLAM PHARMS INC · Approved 2019-11-20
## Drug
- **FDA Application Number:** NDA212194
- **Application type:** New Drug Application
- **Brand name:** GIVLAARI
- **Generic name:** GIVOSIRAN SODIUM
- **Active ingredients:** GIVOSIRAN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ALNYLAM PHARMS INC
- **Manufacturer:** Alnylam Pharmaceuticals, Inc.
- **First approval:** 2019-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212194)
---
*MORVS · CC0 1.0*